Regulatory T cells restrain pathogenic T helper cells during skin inflammation
Following the July 2025 CVS Caremark formulary change, we observed an immediate increase in switching from AOM tirzepatide, while patients with an active supply of AOM semaglutide showed stable or even slightly reduced switching during the same period, consistent with its designation as the preferred option
Patients with intermediate or high risk of coronary artery disease had significantly increased MP accumulations compared to their low-risk counterparts
We do firmly believe that the FDA was premature on both [tirzepatide and semaglutide] shortages
These tools reveal what the bathroom scale cannot: if you've lost 8 pounds of fat while gaining 2 pounds of muscle through exercise, the scale shows only a 6-pound loss, but your body composition has improved dramatically
Rybelsus Advantages: No injections, easier acceptance among some patients, convenient oral dosing, suitable for those preferring tablets